Advicenne is a biopharmaceutical company focused on the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications.
The Company's goal is to improve the lives of patients from early childhood through adulthood by leveraging pharmaceutical and clinical development expertise to develop pediatric friendly therapeutics that answer critical unmet medical needs in the field of rare and neglected diseases.
Type | Public | |
Founded | 2007 | |
HQ | Nîmes, FR | Map |
Website | advicenne.com |
Market capitalization (8-Feb-2021) | 107.6m |
Closing stock price (8-Feb-2021) | 12.5 |
When was Advicenne founded?
Advicenne was founded in 2007.
Who are Advicenne key executives?
Advicenne's key executives are André Ulmann, Caroline Roussel-Maupetit and Nathalie Lemarié.
How many employees does Advicenne have?
Advicenne has 29 employees.
Who are Advicenne competitors?
Competitors of Advicenne include MyoKardia, Athersys and Reata Pharmaceuticals.
Where is Advicenne headquarters?
Advicenne headquarters is located at 2 Rue Briçonnet, Nîmes.
Where are Advicenne offices?
Advicenne has offices in Nîmes, Montbonnot-Saint-Martin and Paris.
How many offices does Advicenne have?
Advicenne has 3 offices.
Receive alerts for 300+ data fields across thousands of companies